[go: up one dir, main page]

ZA200907355B - Titration of tapentadol - Google Patents

Titration of tapentadol

Info

Publication number
ZA200907355B
ZA200907355B ZA200907355A ZA200907355A ZA200907355B ZA 200907355 B ZA200907355 B ZA 200907355B ZA 200907355 A ZA200907355 A ZA 200907355A ZA 200907355 A ZA200907355 A ZA 200907355A ZA 200907355 B ZA200907355 B ZA 200907355B
Authority
ZA
South Africa
Prior art keywords
tapentadol
titration
administration
unitbcontaining
unitacontaining
Prior art date
Application number
ZA200907355A
Other languages
English (en)
Inventor
Claudia Lange
Ferdinand Rombout
Original Assignee
Gruenenthal Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=38123877&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ZA200907355(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Gruenenthal Gmbh filed Critical Gruenenthal Gmbh
Publication of ZA200907355B publication Critical patent/ZA200907355B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Physiology (AREA)
  • Nutrition Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Adhesive Tapes (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ZA200907355A 2007-04-23 2009-10-20 Titration of tapentadol ZA200907355B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP07008218A EP1985292A1 (en) 2007-04-23 2007-04-23 Titration of tapentadol

Publications (1)

Publication Number Publication Date
ZA200907355B true ZA200907355B (en) 2010-08-25

Family

ID=38123877

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200907355A ZA200907355B (en) 2007-04-23 2009-10-20 Titration of tapentadol

Country Status (21)

Country Link
US (4) US20090012180A1 (xx)
EP (5) EP1985292A1 (xx)
JP (4) JP5933176B2 (xx)
KR (3) KR20150027840A (xx)
CN (1) CN101730530B (xx)
AT (1) ATE534378T1 (xx)
AU (1) AU2008241013B2 (xx)
CA (1) CA2683786C (xx)
CY (1) CY1112320T1 (xx)
DK (1) DK2148670T3 (xx)
ES (1) ES2378255T3 (xx)
HR (1) HRP20120147T1 (xx)
IL (1) IL201479A (xx)
MX (1) MX2009011444A (xx)
NZ (1) NZ580415A (xx)
PL (1) PL2148670T3 (xx)
PT (1) PT2148670E (xx)
RU (1) RU2472497C2 (xx)
SI (1) SI2148670T1 (xx)
WO (1) WO2008128740A1 (xx)
ZA (1) ZA200907355B (xx)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1985292A1 (en) * 2007-04-23 2008-10-29 Grünenthal GmbH Titration of tapentadol
DK2352494T3 (da) * 2008-10-30 2019-10-28 Gruenenthal Gmbh Nye og potente tapentadoldoseringsformer
US8870876B2 (en) * 2009-02-13 2014-10-28 Tarsus Medical Inc. Methods and devices for treating hallux valgus
US8277459B2 (en) * 2009-09-25 2012-10-02 Tarsus Medical Inc. Methods and devices for treating a structural bone and joint deformity
US8652141B2 (en) 2010-01-21 2014-02-18 Tarsus Medical Inc. Methods and devices for treating hallux valgus
WO2011138037A2 (de) * 2010-05-05 2011-11-10 Ratiopharm Gmbh Festes tapentadol in nicht-kristalliner form
US8696719B2 (en) 2010-06-03 2014-04-15 Tarsus Medical Inc. Methods and devices for treating hallux valgus
HRP20161166T1 (hr) * 2010-06-30 2016-11-04 Grünenthal GmbH Tapentadol za uporabu u liječenju sindroma iritabilnog crijeva
EP3656765B1 (en) * 2010-07-23 2021-04-14 Grünenthal GmbH Salts or co-crystals of 3-(3-dimethylamino-1-ethyl-2-methyl-propyl)-phenol
CN101948397A (zh) * 2010-09-07 2011-01-19 天津泰普药品科技发展有限公司 镇痛药他喷他多重要中间体的制备方法
RS56692B1 (sr) 2011-03-04 2018-03-30 Gruenenthal Gmbh Polučvrsta vodena farmaceutska kompozicija koja sadrži tapentadol
PT2680832T (pt) 2011-03-04 2019-10-28 Gruenenthal Gmbh Formulação farmacêutica aquosa de tapentadol para administração oral
MX348831B (es) * 2011-03-04 2017-06-30 Gruenenthal Gmbh Administración parenteral de tapentadol.
EP2694050B1 (en) * 2011-04-05 2019-10-02 Grünenthal GmbH Tapentadol for use in treating pain associated with trigeminal neuralgia
WO2012136349A1 (en) * 2011-04-05 2012-10-11 Grünenthal GmbH Tapentadol for preventing chronification of pain
RS60152B1 (sr) 2011-04-29 2020-05-29 Gruenenthal Gmbh Tapentadol za sprečavanje i lečenje depresije i anksioznosti
JP6255474B2 (ja) * 2013-03-15 2017-12-27 マリンクロッド エルエルシー 機能的割線を有する即時放出用の乱用抑止性固体剤形
EP2845625A1 (en) * 2013-09-04 2015-03-11 Grünenthal GmbH Tapentadol for use in the treatment of fibromyalgia and chronic fatigue syndrome
HRP20190231T1 (hr) 2015-03-27 2019-04-05 Grünenthal GmbH Stabilna formulacija za parenteralnu primjenu tapentadola
CN107660147B (zh) * 2015-05-26 2021-04-30 抗菌技术生物技术研究与发展股份有限公司 用于治疗帕金森病和相关障碍的组合物
BR112018017167A2 (pt) * 2016-02-29 2019-01-02 Gruenenthal Gmbh titulação de cebranopadol
JP7160799B2 (ja) 2016-09-23 2022-10-25 グリュネンタール・ゲゼルシャフト・ミト・ベシュレンクテル・ハフツング タペンタドールの非経口投与用安定製剤
AU2021237693A1 (en) 2020-03-16 2022-09-08 Grünenthal GmbH Scored tablet
KR20230156952A (ko) * 2021-03-17 2023-11-15 액테리온 파마슈티칼 리미티드 약제 투여 시스템
EP4333820A1 (en) * 2021-05-07 2024-03-13 Grünenthal GmbH Tapentadol for treating neuropathic pain in covid-19 patients

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4765989A (en) 1983-05-11 1988-08-23 Alza Corporation Osmotic device for administering certain drugs
US4612008A (en) 1983-05-11 1986-09-16 Alza Corporation Osmotic device with dual thermodynamic activity
US4783337A (en) * 1983-05-11 1988-11-08 Alza Corporation Osmotic system comprising plurality of members for dispensing drug
JPS6327805A (ja) 1986-07-21 1988-02-05 Sumitomo Electric Ind Ltd 光フアイバの接続用部材及びそれを用いた接続方法
DE4426245A1 (de) * 1994-07-23 1996-02-22 Gruenenthal Gmbh 1-Phenyl-3-dimethylamino-propanverbindungen mit pharmakologischer Wirkung
US6339105B1 (en) * 1999-10-12 2002-01-15 Ortho-Mcneil Pharmaceutical, Inc. Analgesic regimen
PE20030527A1 (es) * 2001-10-24 2003-07-26 Gruenenthal Chemie Formulacion farmaceutica con liberacion retardada que contiene 3-(3-dimetilamino-1-etil-2-metil-propil) fenol o una sal farmaceuticamente aceptable del mismo y tabletas para administracion oral que la contienen
MXPA05006334A (es) 2002-12-13 2005-08-26 Euro Celtique Sa Dosis de buprenorfina transdermica para analgesia.
US7413749B2 (en) * 2003-03-11 2008-08-19 Purdue Pharma L.P. Titration dosing regimen for controlled release tramadol
EP1985292A1 (en) 2007-04-23 2008-10-29 Grünenthal GmbH Titration of tapentadol
DE102007019417A1 (de) 2007-04-23 2008-11-13 Grünenthal GmbH Tapentadol zur Schmerzbehandlung bei Arthrose

Also Published As

Publication number Publication date
MX2009011444A (es) 2009-11-05
ATE534378T1 (de) 2011-12-15
IL201479A (en) 2016-04-21
JP5933176B2 (ja) 2016-06-08
EP2148670A1 (en) 2010-02-03
EP3603630A1 (en) 2020-02-05
PT2148670E (pt) 2012-01-24
IL201479A0 (en) 2010-05-31
HK1140940A1 (en) 2010-10-29
NZ580415A (en) 2012-04-27
US20190290603A1 (en) 2019-09-26
CA2683786C (en) 2021-10-26
CY1112320T1 (el) 2015-12-09
EP3143993A1 (en) 2017-03-22
EP2148670B1 (en) 2011-11-23
JP2010531296A (ja) 2010-09-24
AU2008241013A1 (en) 2008-10-30
DK2148670T3 (da) 2012-03-12
RU2472497C2 (ru) 2013-01-20
KR20180004839A (ko) 2018-01-12
JP2019131598A (ja) 2019-08-08
PL2148670T3 (pl) 2012-04-30
JP2016128468A (ja) 2016-07-14
US20160074342A1 (en) 2016-03-17
AU2008241013B2 (en) 2013-06-20
RU2009142940A (ru) 2011-05-27
WO2008128740A1 (en) 2008-10-30
US20170079938A1 (en) 2017-03-23
CN101730530A (zh) 2010-06-09
CN101730530B (zh) 2013-10-23
EP2422778A1 (en) 2012-02-29
KR102078999B1 (ko) 2020-02-19
KR20100017267A (ko) 2010-02-16
EP1985292A1 (en) 2008-10-29
ES2378255T3 (es) 2012-04-10
CA2683786A1 (en) 2008-10-30
WO2008128740A8 (en) 2010-06-17
US11344512B2 (en) 2022-05-31
KR20150027840A (ko) 2015-03-12
HRP20120147T1 (hr) 2012-03-31
SI2148670T1 (sl) 2012-03-30
JP2018030864A (ja) 2018-03-01
US20090012180A1 (en) 2009-01-08

Similar Documents

Publication Publication Date Title
ZA200907355B (en) Titration of tapentadol
MX2010009222A (es) Soluciones farmaceuticas, proceso de preparacion y usos terapeuticos.
MY151048A (en) Use of flibanserin for the treatment of post-menopausal sexual desire disorders
MX2009002196A (es) Oblea de buprenorfina para terapia de sustitucion de farmacos.
MY153408A (en) Novel methods
WO2010014690A3 (en) Medical devices for therapeutic agent delivery
UA105210C2 (ru) Противораковая вакцина и ее применение
MX2011007930A (es) Conjugados de insulina cristalina.
MX2014004862A (es) Formulaciones de polimero acrilico.
IN2012DN01435A (xx)
WO2008087186A3 (en) Peptides for use in the treatment of obesity
CY1115455T1 (el) Χρησιμοποιηση ενωσεων 1-φαινυλο-3-διμεθυλαμινο-προπανιου για τη θεραπεια του πονου νευροπαθειας
TN2012000515A1 (en) Pharmaceutical compositions of co-crystals of tramadol and coxibs
WO2011026125A3 (en) Gastric retentive pharmaceutical compositions for immediate and extended release of acetaminophen
IN2012DN01434A (xx)
MX2010001449A (es) Bromhidrato de bupropion y aplicaciones terapeuticas.
WO2008087188A3 (en) Peptides for use in the treatment of obesity
WO2012100043A3 (en) Controlled release oral pharmaceutical dosage forms comprising mgbg
MY150931A (en) Substituted oxazolidinones and their use
UA97401C2 (ru) Экструдат с улучшенной маскировкой вкуса
MX2009008108A (es) Composicion farmaceutica que contiene una combinacion de tramadol y ketoprofeno.
WO2009074498A8 (en) Medical use of 3- (2, 2, 2-trimethylhydrazinixm) propionate orotate
MX2009008813A (es) Composicion farmaceutica que contiene floroglucinol y paracetamol.
WO2007135123A3 (en) Mirtazapine for the treatment of neuropathic pain
EA201000738A1 (ru) Медицинское применение 3-(2,2,2-триметилгидразиниум)пропионат гидрофумарата и дигидрофосфата